Fmr LLC Nu Cana PLC Transaction History

Fmr LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.59 - $1.06 $141,676 - $254,536	-240,129 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.74 - $3.27 $284,308 - $1.26 Million	-384,200 Reduced 61.54%	240,129 $240,000
Q4 2021 Feb 14, 2022	SELL	$2.02 - $2.9 $5,597 - $8,035	-2,771 Reduced 0.44%	624,329 $1.49 Million
Q3 2021 Nov 15, 2021	SELL	$1.95 - $2.85 $1 - $2	-1 Reduced -0.0%	627,100 $0
Q2 2021 Aug 13, 2021	BUY	$2.7 - $5.04 $1.69 Million - $3.16 Million	627,101 New	627,101 $0

3.34M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $133M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

Stay updated on Fmr LLC with notifications on news.